EVNIN ANTHONY B
Insider CIK 1239241 · INFI Director · XLRN Director · AVEO Director · CNST Director, 10% owner · JUNO Director · CMD Director · PARS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 4,000 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 4,000 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 7,785 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 6,402 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 2,000 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 2,515 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 1,250 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 1,250 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 22,500 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 12,500 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 4,000 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer | 2023-01-19 | 2023-01-19 | 41,841 | $15.00 | $627.6K | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2022-06-16 | 2022-06-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2022-06-16 | 2022-06-16 | 46,378 | $0.68 | $31.5K | 215,403 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | A Award deriv | 2022-06-07 | 2022-06-08 | 22,500 | — | $0 | 22,500 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2021-06-10 | 2021-06-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2021-06-10 | 2021-06-11 | 3,061 | $3.43 | $10.5K | 169,025 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | A Award deriv | 2021-06-09 | 2021-06-09 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CMD CANTEL MEDICAL CORP | D To issuer | 2021-06-02 | 2021-06-02 | 12,132 | $80.59 | $977.7K | 0 | SEC↗ |
| CMD CANTEL MEDICAL CORP | A Award | 2020-07-31 | 2020-07-31 | 1,935 | — | $0 | 12,132 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2020-06-17 | 2020-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2020-06-17 | 2020-06-18 | 22,826 | — | $0 | 165,964 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | A Award deriv | 2020-06-10 | 2020-06-30 | 4,000 | — | $0 | 4,000 | SEC↗ |
| CMD CANTEL MEDICAL CORP | P Buy | 2020-03-26 | 2020-03-27 | 1,200 | $40.37 | $48.4K | 8,897 | SEC↗ |
| CMD CANTEL MEDICAL CORP | P Buy | 2020-03-26 | 2020-03-27 | 1,300 | $37.40 | $48.6K | 10,197 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | P Buy | 2019-12-13 | 2019-12-16 | 400,000 | $34.50 | $13.80M | 5,742,765 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | P Buy | 2019-10-03 | 2019-10-04 | 2,823,529 | $8.50 | $24.00M | 5,342,765 | SEC↗ |
| CMD CANTEL MEDICAL CORP | A Award | 2019-07-31 | 2019-08-02 | 713 | — | $0 | 7,697 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2019-06-13 | 2019-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2019-06-13 | 2019-06-14 | 13,125 | $1.60 | $21.0K | 143,138 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2019-06-12 | 2019-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2019-06-06 | 2019-06-10 | 13,171 | — | $0 | 13,171 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-21 | 2018-11-26 | 109 | $2.05 | $223 | 109 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | S Sale | 2018-11-16 | 2018-11-16 | 151,035 | $1.82 | $274.9K | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | S Sale | 2018-11-15 | 2018-11-16 | 670,894 | $1.86 | $1.25M | 151,035 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | S Sale | 2018-11-14 | 2018-11-16 | 325,139 | $1.90 | $617.8K | 821,929 | SEC↗ |
| CMD CANTEL MEDICAL CORP | A Award | 2018-07-31 | 2018-08-10 | 712 | — | $0 | 6,984 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 10,000,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 9,500,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 3,750,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 664,894 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 888,888 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 1,208,674 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | P Buy | 2018-07-23 | 2018-07-23 | 133,334 | $15.00 | $2.00M | 2,519,236 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion | 2018-07-23 | 2018-07-23 | 2,385,902 | — | $0 | 2,385,902 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2018-06-18 | 2018-06-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2018-06-12 | 2018-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2018-06-12 | 2018-06-14 | 2,000 | — | $0 | 2,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2018-06-12 | 2018-06-14 | 11,428 | $1.75 | $20.0K | 130,013 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 12,000 | $27.00 | $324.0K | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 12,000 | $63.71 | $764.5K | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 12,000 | $44.60 | $535.2K | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | G Gift | 2018-02-14 | 2018-03-07 | 34,842 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | G Gift | 2018-02-09 | 2018-03-07 | 25,000 | — | $0 | 34,842 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2018-01-05 | 2018-01-09 | 150 | — | $0 | 59,842 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-10-05 | 2017-10-06 | 161 | — | $0 | 59,692 | SEC↗ |
| CMD CANTEL MEDICAL CORP | A Award | 2017-07-31 | 2017-08-01 | 510 | — | $0 | 6,272 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | G Gift | 2017-07-06 | 2017-07-07 | 7,000 | — | $0 | 59,531 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-07-05 | 2017-07-07 | 230 | — | $0 | 66,531 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2017-06-21 | 2017-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2017-06-21 | 2017-06-23 | 57,857 | — | $0 | 57,857 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | P Buy | 2017-06-20 | 2017-06-21 | 9,000 | $24.40 | $219.6K | 66,301 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2017-06-16 | 2017-06-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2017-05-25 | 2017-05-26 | 2,000 | — | $0 | 2,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2017-05-25 | 2017-05-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2017-05-25 | 2017-05-26 | 11,494 | $1.74 | $20.0K | 118,585 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-04-05 | 2017-04-06 | 311 | — | $0 | 57,301 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | J Other | 2017-03-28 | 2017-03-30 | 250,000 | $0.50 | $125.0K | 418,414 | SEC↗ |
| CMD CANTEL MEDICAL CORP | P Buy | 2017-03-15 | 2017-03-17 | 2,500 | $77.88 | $194.7K | 5,762 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | P Buy | 2017-03-10 | 2017-03-13 | 8,000 | $22.11 | $176.9K | 56,990 | SEC↗ |
| CMD CANTEL MEDICAL CORP | P Buy | 2017-01-18 | 2017-01-19 | 2,000 | $76.26 | $152.5K | 3,262 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2017-01-06 | 2017-01-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CMD CANTEL MEDICAL CORP | A Award | 2017-01-05 | 2017-01-09 | 1,262 | — | $0 | 1,262 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-01-05 | 2017-01-09 | 715 | — | $0 | 48,990 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2016-10-05 | 2016-10-17 | 485 | — | $0 | 48,275 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | G Gift | 2016-08-23 | 2016-08-25 | 10,937 | — | $0 | 47,790 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2016-07-05 | 2016-07-05 | 363 | — | $0 | 58,727 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2016-06-17 | 2016-06-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2016-06-17 | 2016-06-21 | 2,000 | — | $0 | 2,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2016-06-17 | 2016-06-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2016-06-17 | 2016-06-21 | 13,157 | $1.52 | $20.0K | 107,091 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2016-05-26 | 2016-05-31 | 44,021 | — | $0 | 44,021 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2016-05-26 | 2016-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2016-05-13 | 2016-05-17 | 129,533 | — | $0 | 129,533 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award | 2016-05-13 | 2016-05-17 | 129,533 | — | $0 | 168,414 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2016-04-05 | 2016-04-07 | 364 | — | $0 | 58,364 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | P Buy | 2016-03-28 | 2016-03-30 | 3,946 | $36.22 | $142.9K | 53,946 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | P Buy | 2016-03-28 | 2016-03-30 | 4,054 | $36.94 | $149.8K | 58,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | G Gift | 2016-03-17 | 2016-03-30 | 15,000 | — | $0 | 50,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | G Gift | 2015-12-15 | 2015-12-18 | 10,000 | — | $0 | 65,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2015-09-01 | 2015-09-03 | 2,034 | $8.60 | $17.5K | 93,934 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-07-27 | 2015-07-29 | 146,614 | $47.82 | $7.01M | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-07-27 | 2015-07-29 | 80,740 | $48.26 | $3.90M | 146,614 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-26 | 2015-06-29 | 173,713 | $46.57 | $8.09M | 692,953 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-26 | 2015-06-29 | 31,225 | $48.31 | $1.51M | 583,333 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-26 | 2015-06-29 | 78,395 | $47.55 | $3.73M | 614,558 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-25 | 2015-06-29 | 1,800 | $50.99 | $91.8K | 866,666 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-25 | 2015-06-29 | 85,800 | $50.26 | $4.31M | 868,466 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-25 | 2015-06-29 | 71,725 | $49.19 | $3.53M | 954,266 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-25 | 2015-06-29 | 140,675 | $48.39 | $6.81M | 1,025,991 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-18 | 2015-06-19 | 78,569 | $52.07 | $4.09M | 1,371,430 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-18 | 2015-06-19 | 154,495 | $52.74 | $8.15M | 1,216,935 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-18 | 2015-06-19 | 50,269 | $53.58 | $2.69M | 1,166,666 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-17 | 2015-06-19 | 12,000 | $56.32 | $675.8K | 1,449,999 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-17 | 2015-06-19 | 11,602 | $55.85 | $648.0K | 1,461,999 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-17 | 2015-06-19 | 28,603 | $54.70 | $1.56M | 1,473,601 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-17 | 2015-06-19 | 63,574 | $53.84 | $3.42M | 1,502,204 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-17 | 2015-06-19 | 94,080 | $52.65 | $4.95M | 1,565,778 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-17 | 2015-06-19 | 90,141 | $51.59 | $4.65M | 1,659,858 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2015-06-15 | 2015-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2015-06-15 | 2015-06-16 | 2,000 | — | $0 | 2,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2015-06-12 | 2015-06-16 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2015-05-28 | 2015-06-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2015-04-02 | 2015-04-06 | 25,155 | — | $0 | 25,155 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award | 2015-01-02 | 2015-01-06 | 8,025 | $0.88 | $7.1K | 38,881 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 1,749,999 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 1,749,999 | — | $0 | 1,749,999 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2014-10-03 | 2014-10-06 | 7,500 | — | $0 | 7,500 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2014-10-03 | 2014-10-06 | 10,000 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2014-10-03 | 2014-10-06 | 6,000 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2014-10-03 | 2014-10-06 | 1,000 | — | $0 | 1,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2014-10-03 | 2014-10-06 | 10,000 | $12.94 | $129.4K | 83,400 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2014-10-03 | 2014-10-06 | 7,500 | $11.85 | $88.9K | 90,900 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2014-10-03 | 2014-10-06 | 1,000 | $11.85 | $11.8K | 91,900 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2014-10-03 | 2014-10-06 | 6,000 | $12.94 | $77.6K | 73,400 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award | 2014-10-01 | 2014-10-02 | 6,305 | $1.12 | $7.1K | 30,856 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2014-09-30 | 2014-10-02 | 112,451 | $13.56 | $1.52M | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award | 2014-07-01 | 2014-07-02 | 3,901 | $1.81 | $7.1K | 24,551 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2014-06-19 | 2014-06-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2014-06-17 | 2014-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2014-06-17 | 2014-06-19 | 2,000 | — | $0 | 2,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award | 2014-04-01 | 2014-04-02 | 4,556 | $1.55 | $7.1K | 20,650 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award | 2014-01-02 | 2014-01-06 | 3,923 | $1.80 | $7.1K | 16,094 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2013-12-05 | 2013-12-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2013-12-02 | 2013-12-04 | 17,756 | $14.56 | $258.5K | 112,451 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2013-11-27 | 2013-11-27 | 1,200 | $14.56 | $17.5K | 130,207 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2013-11-26 | 2013-11-27 | 138,961 | $14.72 | $2.05M | 131,407 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2013-11-25 | 2013-11-27 | 23,703 | $15.40 | $365.0K | 270,368 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award | 2013-10-01 | 2013-10-03 | 3,395 | $2.08 | $7.1K | 12,171 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 39,175 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 293,143 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | J Other deriv | 2013-09-24 | 2013-09-26 | 118,240 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 507,665 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 1,376,249 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 79,617 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 293,143 | — | $0 | 2,186,789 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 507,665 | — | $0 | 1,893,646 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 39,175 | — | $0 | 2,225,964 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 79,617 | — | $0 | 2,496,152 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 1,376,249 | — | $0 | 1,385,981 | SEC↗ |
| XLRN ACCELERON PHARMA INC | J Other | 2013-09-24 | 2013-09-26 | 190,571 | — | $0 | 2,416,535 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award | 2013-07-01 | 2013-07-02 | 2,758 | $2.56 | $7.1K | 8,776 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2013-06-11 | 2013-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2013-06-11 | 2013-06-12 | 2,000 | — | $0 | 2,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2013-05-29 | 2013-05-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award | 2013-04-01 | 2013-04-24 | 1,034 | $7.25 | $7.5K | 6,018 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2012-11-29 | 2012-11-29 | 4,832 | $24.62 | $119.0K | 294,071 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2012-11-27 | 2012-11-28 | 1,875 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2012-11-27 | 2012-11-28 | 10,000 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2012-11-27 | 2012-11-28 | 9,375 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2012-11-27 | 2012-11-28 | 9,375 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2012-11-27 | 2012-11-28 | 5,625 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2012-11-27 | 2012-11-28 | 9,375 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2012-11-27 | 2012-11-28 | 5,625 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2012-11-27 | 2012-11-28 | 1,407 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2012-11-27 | 2012-11-28 | 6,000 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2012-11-27 | 2012-11-28 | 10,000 | $6.80 | $68.0K | 53,580 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2012-11-27 | 2012-11-28 | 1,875 | $15.04 | $28.2K | 2,798 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2012-11-27 | 2012-11-28 | 6,000 | $6.80 | $40.8K | 59,580 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2012-11-27 | 2012-11-28 | 1,407 | $9.23 | $13.0K | 4,205 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2012-11-27 | 2012-11-28 | 5,625 | $6.74 | $37.9K | 43,580 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2012-11-27 | 2012-11-28 | 9,375 | $6.74 | $63.2K | 37,955 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2012-11-27 | 2012-11-28 | 5,625 | $5.63 | $31.7K | 28,580 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2012-11-27 | 2012-11-28 | 9,375 | $5.63 | $52.8K | 22,955 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2012-11-27 | 2012-11-28 | 9,375 | $7.70 | $72.2K | 13,580 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2012-11-27 | 2012-11-29 | 17,648 | $25.28 | $446.1K | 298,903 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | J Other | 2012-11-26 | 2013-04-10 | 8,743 | — | $0 | 67,400 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | J Other | 2012-11-26 | 2012-11-28 | 923 | — | $0 | 923 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | J Other | 2012-11-26 | 2012-11-28 | 4,832 | — | $0 | 316,551 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | J Other | 2012-11-26 | 2012-11-28 | 864,565 | — | $0 | 311,719 | SEC↗ |
| PARS PHARMOS CORP | A Award deriv | 2012-07-02 | 2012-07-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2012-05-30 | 2012-06-12 | 12,500 | — | $0 | 12,500 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2012-05-16 | 2012-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2012-05-16 | 2012-05-17 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PARS PHARMOS CORP | A Award deriv | 2012-01-09 | 2012-01-11 | 25,000 | — | $0 | 25,000 | SEC↗ |